EFSD, JDRF and Novo Nordisk: European Programme in Type 1 Diabetes Research

The aim of the Programme is to advance current knowledge in this domain. The specific goals of the Programme are to:
I. promote the highest quality of basic and clinical biomedical research in Europe and its associated countries applicable to type 1 diabetes;
II. expedite the practical application of scientific advances in our understanding of the aetiology, pathogenesis, treatment and prevention of type 1 diabetes and its complications;
III.encourage clinical translational research bridging the bench and the bedside;
VI. increase awareness of type 1 diabetes research throughout Europe.
Funding: of up to €100K (up to €400K might be considered on a case-by-case basis special requests) over 1 to 3 years.